These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31266372)

  • 1. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
    Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
    FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-26a-5p Heightens Breast Cancer Cell Sensitivity to Paclitaxel via Targeting Flap Endonuclease 1.
    Cai Y; Zhang T; Chen G; Liu C
    Ann Clin Lab Sci; 2023 Jan; 53(1):116-125. PubMed ID: 36889769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
    Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development.
    Ma D; Wu J; Chen C; Niu Y; Ji K; Xiao Y; Guan Q
    Biochem Genet; 2024 Jun; 62(3):2082-2099. PubMed ID: 37851210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
    Li C; Zhou D; Hong H; Yang S; Zhang L; Li S; Hu P; Ren H; Mei Z; Tang H
    Aging (Albany NY); 2019 Aug; 11(15):5593-5612. PubMed ID: 31402791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
    He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
    EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding.
    Guo Z; Zheng L; Xu H; Dai H; Zhou M; Pascua MR; Chen QM; Shen B
    Nat Chem Biol; 2010 Oct; 6(10):766-73. PubMed ID: 20729856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.
    Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z
    J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitic acid reduces the methylation of the FOXO1 promoter to suppress the development of diffuse large B-cell lymphoma via modulating the miR-429/DNMT3A axis.
    Li W; Gao M; Xue W; Li X; Chang Y; Zhang K; Wen C; Zhang M
    Chin J Nat Med; 2024 Jun; 22(6):554-567. PubMed ID: 38906602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fen1 mutations that specifically disrupt its interaction with PCNA cause aneuploidy-associated cancer.
    Zheng L; Dai H; Hegde ML; Zhou M; Guo Z; Wu X; Wu J; Su L; Zhong X; Mitra S; Huang Q; Kernstine KH; Pfeifer GP; Shen B
    Cell Res; 2011 Jul; 21(7):1052-67. PubMed ID: 21383776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endonuclease FEN1 mediates activation of STAT3 and facilitates proliferation and metastasis in breast cancer.
    Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
    Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
    Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
    Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.
    Yin X; Wang J; Shan C; Jia Q; Bian Y; Zhang H
    Bioengineered; 2022 Mar; 13(3):6929-6941. PubMed ID: 35236250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-4324 inhibits ovarian cancer progression by targeting FEN1.
    Wu H; Yan Y; Yuan J; Luo M; Wang Y
    J Ovarian Res; 2022 Mar; 15(1):32. PubMed ID: 35246224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
    Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
    Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
    Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
    Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer.
    Zhang H; Ge Z; Wang Z; Gao Y; Wang Y; Qu X
    Aging (Albany NY); 2021 Mar; 13(6):8115-8126. PubMed ID: 33686957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.